Tag: NASDAQ:OMER

business, Finance

Stocks to watch: Cavium Inc (NASDAQ:CAVM), Omeros Corporation (NASDAQ:OMER), EDAP (NASDAQ:EDAP), BGC Partners (NASDAQ:BGCP), Intersil Corp (NASDAQ:ISIL)

Cavium, Inc. (NASDAQ:CAVM), a leading provider of semiconductor products that enable intelligent processing for enterprise, data center, cloud, wired and wireless networking, on 03 June 2014 announced the introduction of a new game changing category of processors that are workload optimized for a range of applications in the cloud and data center. The 2.5GHz 48 core ThunderX is the world’s highest performing low-power 64-bit ARMv8 … Continue reading Stocks to watch: Cavium Inc (NASDAQ:CAVM), Omeros Corporation (NASDAQ:OMER), EDAP (NASDAQ:EDAP), BGC Partners (NASDAQ:BGCP), Intersil Corp (NASDAQ:ISIL)

Ryan Holtz
Gilead Sciences GILD NASDAQ:GILD
Finance

Trending Stocks: OmniVision Technologies, Inc. (NASDAQ:OVTI), Omeros Corporation (NASDAQ:OMER), JD.Com Inc (ADR) (NASDAQ:JD), Halliburton Company (NYSE:HAL)

OmniVision Technologies Inc (NASDAQ:OVTI) was upgraded by Northland Securities from a “market perform” rating to an “outperform” rating in a research note issued on Friday. The firm currently has a $28.00 price objective on the stock, up from their previous price objective of $21.00. Northland Securities’ price objective suggests a potential upside of 39.03% from the company’s current price. OmniVision Technologies, Inc. (NASDAQ:OVTI) stock performance … Continue reading Trending Stocks: OmniVision Technologies, Inc. (NASDAQ:OVTI), Omeros Corporation (NASDAQ:OMER), JD.Com Inc (ADR) (NASDAQ:JD), Halliburton Company (NYSE:HAL)

Kevin Long
Finance

Hot Watch List: The Medicines Company (NASDAQ:MDCO), Omeros Corporation (NASDAQ:OMER), Northwest Biotherapeutics (NASDAQ:NWBO), Dehaier Medical Systems (NASDAQ:DHRM), Durata Therapeutics (NASDAQ:DRTX)

The Medicines Company (NASDAQ:MDCO) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.07) by $0.01. The company had revenue of $177.20 million for the quarter, compared to the consensus estimate of $175.60 million. During the same quarter last year, the company posted ($0.21) earnings per share. The … Continue reading Hot Watch List: The Medicines Company (NASDAQ:MDCO), Omeros Corporation (NASDAQ:OMER), Northwest Biotherapeutics (NASDAQ:NWBO), Dehaier Medical Systems (NASDAQ:DHRM), Durata Therapeutics (NASDAQ:DRTX)

John Bellich
Finance

Biotech Gainers: Cerus Corporation (NASDAQ:CERS), Omeros Corporation (NASDAQ:OMER), Durata Therapeutics Inc (NASDAQ:DRTX), Aastrom Biosciences Inc (NASDAQ:ASTM)

Cerus Corporation (NASDAQ:CERS) and a pharmaceutical unit of Nipro Corporation announced a collaboration agreement. The collaboration will lead to the development of efficient and easy-to-use disposable kit for red cells. The project will benefit from the proprietary technology of Nipro towards the creation a red cell disposable kit that suits the needs of small and large blood centers. Cerus Corporation (NASDAQ:CERS) stock performance was 7.55% … Continue reading Biotech Gainers: Cerus Corporation (NASDAQ:CERS), Omeros Corporation (NASDAQ:OMER), Durata Therapeutics Inc (NASDAQ:DRTX), Aastrom Biosciences Inc (NASDAQ:ASTM)

Adam Keintzel